Tenofovir

Products Tenofovir is commercially available in the form of film-coated tablets (Viread, combination products, generics). It has been approved in many countries since 2002. It is also used to treat chronic hepatitis B. This article refers to HIV. Structure and properties Tenofovir (C9H14N5O4P, Mr = 287.2 g/mol) is present in drugs in the form of … Tenofovir

Tenofoviralafenamide

Products Various drugs containing tenofoviralafenamide are on the market worldwide. In many countries, tenofoviralafenamide was first approved in 2016 (United States: 2015). Biktarvy: bictegravir, emtricitabine, and tenofoviralafenamide (HIV). Genvoya: elvitegravir, cobicistat, emtricitabine, and tenofoviralafenamide (HIV). Descovy: emtricitabine and tenofoviralafenamide (HIV). Odefsey: emtricitabine, rilpivirine and tenofoviralafenamide (HIV). Symtuza: darunavir + cobicistat + emtricitabine + tenofoviralafenamide. Vemlidy: … Tenofoviralafenamide

Dehydrochloromethyltestosterone

Products In many countries, there are no drugs containing dehydrochlormethyltestosterone on the market. The active ingredient was lanicized in the 1960s and distributed by the state-owned VEB Jenapharm, based in Jena, Thuringia (Oral-Turinabol tablets). Structure and properties Dehydrochloromethyltestosterone (C20H27ClO2, Mr = 334.9 g/mol) is a chlorinated derivative of methyltestosterone. Effects Dehydrochloromethyltestosterone has anabolic and androgenic … Dehydrochloromethyltestosterone

Budesonide (Inhalation)

Products Budesonide is commercially available as a monopreparation for inhalation as a powder inhaler and suspension (Pulmicort, generics). It is also combined fixed with formoterol (Symbicort Turbuhaler, Vannair Dosage Aerosol). This article refers to monotherapy. Budesonide has been approved in many countries since 1988. Structure and properties Budesonide (C25H34O6, Mr = 430.5 g/mol) is a … Budesonide (Inhalation)

Budesonide Nasal Spray

Products Budesonide nasal sprays have been approved in many countries since 1995 (Cortinasal, generic). Rhinocort nasal spray has not been marketed since 2018. Sales of the Rhinocort turbuhaler were discontinued in 2020. Structure and properties Budesonide (C25H34O6, Mr = 430.5 g/mol) is a racemate and exists as a white, crystalline, odorless, tasteless powder that is … Budesonide Nasal Spray

Budesonide Capsules

Products Budesonide sustained-release capsules have been approved in many countries since 1998 (Entocort CIR, Budenofalk). Structure and properties Budesonide (C25H34O6, Mr = 430.5 g/mol) is a racemate and exists as a white, crystalline, odorless, tasteless powder that is practically insoluble in water. Effects Budesonide (ATC R03BA02) has anti-inflammatory, antiallergic, and immunosuppressive properties. The effects are … Budesonide Capsules